PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 23 hours 16 minutes
CLL Management in the Relapsed/Refractory Setting: A Look at Novel Targeted Agents on the Horizon
Go online to www.peervoice.com/h/pvs69 to view the entire programme with slides.
Emerging Insights: Optimal Sequencing of Targeted Therapy for Refractory CML
Emerging Insights: Optimal Sequencing of Targeted Therapy for Refractory CML
Evolving Treatment Paradigms in Intermediate-Stage Hepatocellular Carcinoma
Evolving Treatment Paradigms in Intermediate-Stage Hepatocellular Carcinoma
Targeting Metastatic Gastric Cancer: Where Are We Now and Where Are We Going?
Targeting Metastatic Gastric Cancer: Where Are We Now and Where Are We Going?
Opportunities To Evolve Treatment Sequencing in aBC: Insights from San Antonio
Opportunities To Evolve Treatment Sequencing in aBC: Insights from San Antonio
Practical Management of Advanced Basal Cell Carcinoma: A Multidisciplinary Approach
Go online to www.peervoice.com/h/pvr175 to view the entire programme with slides.
New Insights and Strategies for the Management of Acquired Hemophilia A: Updates From San Francisco
Go online to www.peervoice.com/h/pvs67 to view the entire programme with slides.
Breakthroughs and Game-Changers in NSCLC Management: Expert Perspectives on Current Evidence and Practice
Go online to www.peervoice.com/h/pve68 to view the entire programme with slides.
On the Edge of Innovation: The Future of Targeted Agents in Advanced Breast Cancer
Go online to www.peervoice.com/h/pvs67 to view the entire programme with slides.
Management of Multiple Myeloma: Where Are We Now and Where Are We Going?
Management of Multiple Myeloma: Where Are We Now and Where Are We Going?